What is the recommended dosing regimen for Anaferon (synthetic polypeptide) for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anaferon Dosing Regimen

For adults and adolescents 12 years and older, Anaferon is dosed at 1-2 tablets sublingually three to four times daily, taken 30 minutes to one hour before meals and at bedtime, with dosing potentially increased to every 4 hours as needed, not exceeding 12 tablets in 24 hours. 1

Adult and Adolescent Dosing (≥12 years)

The FDA-approved regimen is straightforward:

  • Standard dose: 1-2 tablets sublingually
  • Frequency: 3-4 times daily
  • Timing: 30-60 minutes before meals and at bedtime
  • Maximum: Can increase to every 4 hours if needed, but do not exceed 12 tablets per 24 hours
  • Administration: May be taken with or without water 1

Important Considerations for Geriatric Patients

Elderly patients demonstrate increased sensitivity to the usual adult dose and may require dose adjustment 1. Start at the lower end of the dosing range and monitor closely for anticholinergic effects.

Pediatric Population (<12 years)

This product is contraindicated in children under 12 years of age 1. The FDA labeling explicitly states this medication is not recommended for pediatric use below this age threshold, despite research literature describing a "pediatric formulation" of Anaferon used in various studies 2, 3, 4, 5, 6. These appear to be different formulations or products not covered by the current FDA-approved labeling.

Critical Contraindications

Before prescribing, ensure the patient does not have:

  • Glaucoma
  • Obstructive uropathy or gastrointestinal obstruction
  • Paralytic ileus or intestinal atony (particularly in elderly/debilitated patients)
  • Unstable cardiovascular status
  • Severe ulcerative colitis or toxic megacolon
  • Myasthenia gravis
  • Myocardial ischemia 1

Overdose Management

Signs of overdose include headache, nausea, vomiting, blurred vision, dilated pupils, hot dry skin, dizziness, dry mouth, difficulty swallowing, and CNS stimulation. Treatment involves immediate gastric lavage and physostigmine 0.5-2 mg IV, repeated as necessary up to 5 mg total 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.